Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Marta Ferreira

Marta Ferreira

Interdisciplinary Center for Marine and Environmental Research, Portugal Portugal

Jan Ulfberg

Jan Ulfberg

Capio Sleep Center, Sweden Sweden

Michael V Ugrumov

Michael V Ugrumov

Institute of Developmental Biology RAS, Russia Russia

David Truswell

David Truswell

Somefreshthinking Consultancy, UK UK

Varghese John

Varghese John

University of California, USA USA

Stephen D Skaper

Stephen D Skaper

University of Padua, Italy Italy

Young-Ho Lee

Young-Ho Lee

Hanyang University College of Medicine, South Korea South Korea

Joel B Schachter

Joel B Schachter

Merck Research Laboratories, USA USA

Euro Pharmacology 2019

About Conference


Following the overwhelming success of Congresses held in several European countries, Dubai, Spain, Italy, India, South Africa and USA, the Organizing Committee of Conference Series Ltd is pleased to invite all the participants across the globe to attend the Pharmacology and Drug Safety Conference on June 17-18, 2019 at Lisbon, Portugal.

The conference is a globally organized three-day event which will provide multi-channel communication platform that fetches together both “producers” and “consumers” of the pharma world of generic sector and ethical medicine. It aims to explore novel approaches in pharmacology, Drug Safety Systems and their application in the development of pharmaceutical and healthcare products. The conference program includes prompt keynote presentations, oral talks, poster presentations and exhibitions. It is an ideal platform for researchers, scientists and, delegates to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.

Motives to Attend:

  • Keynote presentation along with interactions to galvanize the scientific community.
  • Workshop and symposiums to reach the largest assemblage of participants from the Pharma community.
  • A wide track of exhibitors to showcase the new and emerging technologies.
  • Platform to global investment community to connect with stakeholders in Pharma sector.
  • Young Scientist/ Investigators Award geared towards best budding young research.
  • Links to the political marketing resources to expand your business and research network.
  • Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.

Target Audience:

  • Researchers
  • Directors, CEO’s of Organizations
  • Scholars from Pharmacology, Pharmaceutical, Toxicology backgrounds
  • PhD Scholars
  • Drug Delivery Technology Manufacturers
  • Business Development Managers
  • Distributors and Suppliers of Drug Delivery Technologies
  • Students, Professors, Researchers, and Faculty of Pharmacology & Pharmaceutical Sciences from Universities and Medical Colleges
  • Researchers from Pharmaceutical Companies, Pharmacy & Pharmacology Associations and Societies
  • Health professionals
  • Pharmacists, Pharmacologists, & Toxicologists
  • Business development professionals, Consultants, Pharma, and  Toxicology Testing service providers
  • Quality control specialists
  • Graduates and post graduates in industrial pharmacy
  • Medical Devices Manufacturing Companies, CRO
  • Data Management Companies.
  • Pharmaceutical legislators and regulators
  • Toxicology Testing Companies & Organizations

About Conferece Venue:

Amsterdam, the capital of the Kingdom of the Netherlands, is one of the most popular tourist destinations in Europe. Amsterdam is located in the western Netherlands, in the province of North Holland. The river Amstel ends in the city centre and connects to a large number of canals. With its universities, academies, and research institutes, along with more than 40 museums, numerous theaters, and entertainment venues, Amsterdam is the country's leading cultural center. In addition, the city is famous for its historic homes, laid out in a pattern of concentric segments in the shape of a fan and built on piles driven through an upper layer of mud into the firm, sandy bottom up to 18 meters below. All told, some 6,750 buildings dating from the 16th to 18th centuries are crowded into an area of 2,000 acres, dissected by 160 canals (grachten), themselves home to numerous houseboats. Many picturesque bridges link the city's 90 islands, eight of them old wooden bascule bridges, including the Magere Brug (Mager Bridge), one of the city's most frequently photographed.

Amsterdam is the financial and business capital of the Netherlands. Amsterdam is ranked fifth best of European cities in which to locate an international business, surpassed by London, Paris, Frankfurt and Barcelona. As the commercial capital of the Netherlands and one of the top financial centres in Europe, Amsterdam is considered an alpha world city by the Globalization and World Cities (GaWC) study group. The city is also the cultural capital of the Netherlands

Amsterdam's main attractions, including its historic canals, the Rijksmuseum, the Van Gogh Museum, the Stedelijk Museum, Royal Palace, Hermitage Amsterdam, West Church, the Anne Frank House, Rembrandt House Museum, Dam Square, the Amsterdam Museum, Maritime Museum, Vondelpark, Bloemenmarkt, Canals of Amsterdam, red-light district, Port of Amsterdam, and its many cannabis coffee shops draw more than 5 million international visitors annually It is also the world's most multicultural city with at least 177 nationalities represented.

Sessions/Tracks

Track 01: Systems Pharmacology

Systems pharmacology helps to understand drug action at the organ and organismal levels. The application of computational and experimental systems biology approaches to pharmacology allows us to expand the definition of systems pharmacology. It helps to include network analyses at multiple scales of biological organization and to explain both therapeutic and adverse effects of drugs. Systems pharmacology analyses rely on experimental "omics" technologies that are capable of measuring changes in large numbers of variables, often at a genome-wide level, to build networks for analyzing drug action.

Related Conferences: Pharmacology Conferences | Pharmacology MeetingsPharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 02: Neuropharmacology & Psychopharmacology

Neuropharmacology can be defined as the study of how cellular functions in the nervous system, got affected by drugs and the neural mechanisms through which they influence behavior. The two main branches of neuropharmacology are behavioral and molecular pharmacology. Behavioral neuropharmacology focuses on how drugs affect human behavior. It also includes the study of how drug addiction and dependence effect on the human brain. Studying these interactions, scientists are developing drugs to treat many different neurological disorders, including pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, addiction, and many others.

Psychopharmacology cab be referred as the study of drug-induced changes in thinking, mood, and behavior. These drugs may take their origin from natural sources such as plants and animals, or from artificial sources such as chemical syntheses in the laboratory. These drugs interact with target sites or receptors within the nervous system and induce widespread physiological changes or psychological functions.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 03: Molecular and Clinical Pharmacology

Molecular Pharmacology, this branch of pharmacology focuses on understanding the nature of the molecular recognition processes between macromolecular targets and drugs. Another major development in molecular pharmacology has been the discipline of pharmacogenomics: the study of how an individual’s genetic makeup influences their responses to therapeutic drugs.

Clinical pharmacology is a branch of biomedical science. It includes drug discovery, the study of the effects of drugs on their targets in living systems and their clinical use, as well as the study of biological function related to these chemicals. Clinical pharmacology includes application of pharmacological principles, such as pharmacodynamics and pharmacokinetics.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 04: Biochemical Pharmacology

Biochemical pharmacology is the branch of pharmacology concerned with the biochemical mechanisms in the body which are responsible for the actions of drugs administered into the body. The route of drug administration generally depends upon the actual biochemical characteristics of the drug and the interaction of drug molecules with the body fluids and tissues.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 05: Nursing and Anesthesia Pharmacology

Nursing pharmacology helps nurses to understand how drugs work in the body.  They enable them to understand the therapeutic effects, anticipate and recognize the potential side effects or toxicities of the drugs administered by the patients. In drug therapy today, nurses, together with physicians and pharmacists, participate in a system of checks and balances designed to promote beneficial effects and minimize harm. Nurses are especially important in this system because it is the nurse—not the physician or pharmacist—who follows the patient’s status most closely. 

Anesthesia pharmacology can be referred to the pharmacological mode of action anesthetics agents after their administration into the body. The practice also deals with the adverse actions, precautions of anesthetics and their interaction with other anesthetics.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 06: Environmental Pharmacology

Environmental pharmacology is a branch of pharmacology. It deals with the entry of harmful chemicals or drugs into the environment after elimination as post-therapy from humans and animals. Environmental pharmacology includes ecopharmacology, pharmacoenvironmentology, and ecotoxicology. The origin of Origins of pharmaceutical and personal care products in the environment are portions of most ingested drugs are excreted in varying unmetabolized amounts (and in undissolved states because of protection by excipients) primarily via the urine and feces, bio-active metabolites, conjugates, free excreted drugs and derivatives can escape degradation in municipal sewage treatment facilities; the conjugates can be hydrolyzed back to the free parent drug, and un-degraded molecules are then discharged to receiving surface waters or find their way to ground waters, e.g., leaching, recharge.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 07: Pharmacoepidemiology

Pharmacoepidemiology is the learning of the application and effects of drugs administered in large figures of people; it provides an estimate of the probability of beneficial effects of a drug in a population and the probability of adverse effects.  Pharmacoepidemiology focusses on clinical patient outcomes from therapeutics. It works by using approaches of clinical epidemiology and by applying them to understanding the determinants of beneficial and adverse drug effects, effects of genetic variation on drugs therapeutic effect, duration-response relationships of drugs, clinical effects of drug-drug interactions, and the effects of medication non-adherence.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 08: Pharmacogenetics & Pharmacogenomics

Pharmacogenetics is the study of variation in drug responses on genetic basis. In this biggest sense, pharmacogenetics comprehends pharmacogenomics, which employs tools for surveying the entire genome to evaluate multigenic determinants of drug response. Until the technical advances in genomics in last few decades, pharmacogenetics proceeded using a forward genetic, phenotype-to-genotype approach. Drug response outliers were compared to individuals with “normal” drug response to identify the pharmacologic basis of altered response.

Pharmacogenomics is the study of how genes affect the response to drugs of an individual. This relatively new field combines pharmacology and genomics to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup. Pharmacogenomic methods are based on recent technical advances that brought the opportunity of highly parallel analysis of genetic information of human as well as model organisms.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 09: Toxicology 

Toxicology can be defined as the study of the adverse effects of chemicals, pharmaceutical chemicals or any other physical agents on living organisms. Adverse effects may occur in many forms, ranging from immediate death to subtle changes not realized until months or years later. They may occur at various levels within the body, from cellular level to organ level and can affect the organism or sometimes a specific biochemical. The safety evaluation of pharma products involves evaluation for the risk that a drug can pose to animals and man with respect to normal physiological function and reproductive performance. Drug safety and efficacy testing are essential for new pharma drugs, biological, herbal and natural remedies, nutraceuticals and probiotic food products, and select cosmetics before they are introduced in the market.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 10: Ethnopharmacology

The study of action and properties of medicinal agents, often derived from plants, indigenous to population or ethnic groups. Ethnopharmacology is an amalgam of perspectives, primarily those of pharmacology, pharmacognosy, anthropology, and botany. Ethnopharmacology has contributed to the discovery of many important plant-derived drugs. Herbalism when combined with phytochemistry and ethnopharmacology is a powerful means for drug discovery. Ethnopharmacology is restricted to natural products used in a traditional context.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 11: Safety Pharmacology

Safety pharmacology studies were generally performed during the drug development stage on the selected candidate drug prior to FiH trials. Currently, the onset of safety pharmacology studies has shifted towards the early drug discovery process. Thus, safety pharmacological studies in addition to assessing and mitigating risks associated with the selected candidate drug can now facilitate lead candidate selection by hazard identification and elimination of new chemical entities with safety liabilities.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 12: Toxicology Testing Methods

Toxicity testing of new compounds is essential for drug development process. The preclinical toxicity testing on various biological systems reveals the species-, organ- and dose- specific toxic effects of an investigational product. There are distinct types of toxicological analyses that are conducted for different purposes. They include forensic toxicological analysisworkplace drug testing, clinical analysis or hospital drug testing. A toxicity test, by extension, is designed to generate data concerning the adverse effects of a substance on human or animal health, or the environment. Most of the toxicity tests examine specific types of adverse effects, known as endpoints, such as eye irritation or cancer. Other tests are more general in nature, ranging from acute (single-exposure) studies to repeat dose (multiple-exposure) studies, in which animals are administered daily doses of a test substances.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 13: Drug Safety or Pharmacovigilance

Pharmacovigilance can be defined as the processes and science of monitoring safety and efficacy of medicines. It is helping to reduce risk and increase benefit. Therefore, the assessment of benefit versus risk must begin during the preclinical evaluation of a medicinal product and must extend throughout its full life cycle. As a result, there is now added focus on safety and risk assessment after a product has received regulatory approval, when it is placed on the market and prescribed to large populations.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 14: Adverse Drug Reporting

Adverse event reporting is done across the life-span of a pharmaceutical product or device – both before and after market approval – to continuously evaluate and analyze its safety profile. Adverse Event data is assessed for classification, reportability, and safety signals. The case reporting process includes entering the data into a safety database. This also includes of composing a narrative of the event and thereby medically coding the adverse event in terms by putting the case report through medical and regulatory review. It also includes the reporting of the case per country or community regulations, to national competent authorities, IRBs/ECs, investigators, and business partners, as applicable.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 15: Risk Management and Analysis

Risk management analysis is a set of interventions designed to identify, characterize, prevent or minimize risks relating to medicinal products. This includes the assessment of the effectiveness of those activities and intervention. All drugs have risks associated with their use, this includes including adverse reactions, interactions between drugs and with environmental factors, as well as the risk that the product may not work as effectively as expected and in conclusion the risk management system can be defined as a set of pharmacovigilance activities in pharmacovigilance. The key point is the balance between benefits and risks.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 16: Ecopharmacovigilance or Pharmacoenvironmentology

Ecopharmacovigilance concerns the adverse events related to drugs within the ecosystem with all consequences in humans and other organisms in the environment. It is the science and activities associated with the detection, evaluation, understanding, and prevention of adverse effects of pharmaceuticals in the environment. It helps to monitor the adverse effects of pharmaceuticals in humans through non-therapeutic environmental exposure.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 17: Postmarketing Surveillance of Drugs

Post-marketing surveillance refers to the search for adverse reactions to drugs that have been cleared for widespread use. Two types of study designs are often used: the cohort study and the case-control study. In a cohort strategy, a large group of treated patients are studied to determine the occurrence of any adverse reactions. In a case-control study, patients who have experienced the adverse reaction are matched with other treated patients who have not. PMS studies are very well adapted to answer questions about prognosis, tolerance, survival, quality of life, benefits and costs of treatment.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 18: Drug Safety Testing

Nonclinical evaluation includes assessment of drug exposure, primarily, according to FDA, parent drug plasma concentration.  The drug safety testing usually consists of a set of standard animal toxicology studies. This Generally, drug plasma concentration and systemic exposure in the nonclinical studies are compared with systemic exposure in humans to assess the potential risks from nonclinical findings and guide monitoring in trials. This includes progress in the field of in vitro models, surrogate models, molecular toxicology, 'omics' technologies, translational safety biomarkersstem-cell based assays and preclinical imaging.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 19: New Horizons of Pharmacovigilance

Pharmacovigilance can be described as the processes for monitoring and evaluating adverse drug reactions of pharmaceutical drugs. It is a key component of effective drug regulation systems, clinical practice and public health programs. Within the last decade, there has been a growing responsiveness that the scope of pharmacovigilance should be stretched beyond the strict confines of detecting new signals of safety concerns.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 20: Major challenges in Pharmacovigilance

Pharmacovigilance is an important and integral part of clinical research. Both clinical trials safety and postmarketing pharmacovigilance are critical throughout the product lifecycle. With many recent high-profile drug withdrawals, the pharmaceutical industry and regulatory agencies have raised the bar. Early detection of signals from both postmarketing surveillance studies and from the clinical trials have now been adapted by major pharmaceutical companies. This helps them to identify the risks associated with the medicinal product and effectively managing the risks by applying robust risk management plans throughout the life cycle of the product.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 21: Global Pharma Market

The drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%. The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and TherapeuticsEuropean Behavioral Pharmacology SocietyEuropean Society of Biochemical PharmacologyEuropean College of NeuropsychopharmacologyEuropean Federation for Pharmaceutical SciencesInternational Society of PharmacovigilanceThe Drug Safety Research Unit: Drug Information AssociationSociety of ToxicologySociety of Environmental Toxicology and Chemistry

Track 22: Pharmaceutical Chemistry, Analysis and Drug Design

Pharmaceutical chemistry is one considered to be pharmaceutical, with deep roots in the chemistry and Sciences border with Pharmacology, studying the design, synthesis and development of molecules with biological activity and drugs for therapeutic purposes. Pharmaceutical chemistry aims the identification, synthesis and the development of new chemical compounds that are suitable for therapeutic use. This includes the study of existing drugs, their biological properties and their quantitative structure-activity relationship. She also studies the quantitative interactions among these molecules and its biological effects. It's a very deep and complex discipline that combines knowledge of organic chemistry, combinatorial chemistry, bioinformatics, biochemistry, pharmacodynamics, biopharmacy and pharmacokinetics.

Related Conferences: Pharmacology Conferences | Pharmacology Meetings | Pharmacology Events | Toxicology Meetings | Toxicology Conferences | Pharmacovigilance Conferences

Recommended Conferences:

5th International Conference on Organic and Inorganic Chemistry, July 28-29, 2018 Paris, France; 8th World Congress on Chromatography, September 13-14, 2018 Prague, Czech Republic; 14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology April 09-11, 2018 Amsterdam, Netherlands; Euro Biopharmaceutics 2018 September 24-25, 2018 Amsterdam, Netherlands; 6th International Conference and Exhibition on Pharmaceutical Formulations July 26-27, 2018 Rome, Italy.

Related Societies:

The Federation of European Pharmacological SocietiesEuropean Association for Clinical Pharmacology and Therapeutics;European Behavioral Pharmacology Society;European Society of Biochemical Pharmacology;European College of Neuropsychopharmacology;European Federation for Pharmaceutical Sciences,International Society of Pharmacovigilance;The Drug Safety Research Unit: Drug Information Association:Society of ToxicologySociety of Environmental Toxicology and Chemistry

Market Analysis

Importance & Scope

The pharmaceutical industry comprises of companies that are engaged in research, development, manufacture and distribution drugs for human or veterinary use. The primary function of the research-based pharmaceutical corporations is to create value by discovering and producing effective medicines, vaccines and services that improve patients’ well-being, and can be sold in markets at a profit. As well as increasing shareholder value, this contributes significantly to the quality and protection of life and helps make the world a better place. In the past 60 years, innovation and technology have driven huge improvements in global health.

 

New drugs have an enormous positive influence on global health, prosperity and economic productivity by saving lives, increasing life spans, reducing suffering, preventing surgeries and shortening hospital stays. Advances in medicine have eliminated deadly diseases and have brought other life-threatening conditions under control. Drug therapy is now an integral part of nearly every facet of healthcare, and new breakthroughs promise to revolutionize the treatment of non-communicable diseases.

Market Analysis of Global Pharmaceutical Industries and Trends Estimation

Over the past few years, the global pharmaceutical and medicine manufacturing industry has experienced moderate growth. The moderate growth has been underpinned by rising demand for healthcare and medications worldwide, especially from emerging economies. Additionally, higher healthcare standards and greater emphasis on illness prevention have given pharmaceuticals a higher significance among consumers, thereby driving sales over the period. In 2014, the global pharmaceutical industry crossed the USD1 trillion mark for the first time, with North America generating more than 40% of these revenues.

The global $1.12 trillion market in 2022, will rise at a faster clip during 2016-2020, then slow down a bit as major patent expiration take hold. It is expected that the global market declined by 1.0% in 2015, but will grow by 4.8% this year. Prescription sales excluding generics will rise 4.4% this year, and expected to reach $1.006 trillion in 2022. Generics sales will increase from $73 billion in 2015 to $115 billion in 2022, and constitute 10.2% of prescription sales at that point only 0.3 percentage points more than it is now.

R&D spending & growth

During the 2008-2015 period, the compound annual growth rate of global R&D spending was 1.7%; during the 2016-2022 period, the rate will grow at 2.8%. The year-over-year increase, however, will remain around 3%, versus some dramatic jumps seen in 2013, 2014 and 2015. Overall spending will reach $182 billion in 2022. Top spenders in 2015 were Roche and Novartis ($8.5 billion each in 2015), Pfizer ($7.7 billion), J&J ($6.8 billion), Merck ($6.6 billion), and Sanofi and AstraZeneca ($5.6 billion each). However, in 2022, J&J will overtake Pfizer, and Sanofi will overtake Merck. The drug discovery services market is expected to reach USD 14.40 Billion by 2022 from USD 8.32 Billion in 2017, at a CAGR of 11.6%. The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services.

The fast-growing division of the pharmaceutical market include generics and biologics. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval.15 U.S. generic drug sales reached an estimated $70 billion, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favoring generics. Although generics make up only 22 percent of total prescription sales, its share of filled prescriptions has risen from 19 percent in 1984 to 88 percent in 2015. The research-based pharmaceutical industry is estimated to have spent nearly USD 149.8 billion globally on pharmaceutical R&D in 2015-16. Among all the industrial sectors, the research-based pharmaceutical industry has consistently invested the most in research and development, even in times of economic turmoil and monetary crisis.

When compared with other high-technology industries, the annual spending by the pharmaceutical industry is 5.5 times greater than that of the aerospace and defense industries, 5 times more than that of the chemicals industry, and 1.8 times more than that of the software and computer services industry.

According to the QuintilesIMS Institute predicts that the pharmaceutical market by 2021 will reach nearly USD 1,485 billion, by an increase of USD 350-380 billion from the USD 1,105 billion recorded in 2016. This growth is coming mainly from market expansion in pharmerging countries117 and demographic trends in developed countries due to an ageing population. Global brand spending is forecast to increase to USD 815-832 billion in 2021. Global generic spending is expected to increase to USD 495-505 billion by 2021.

The United States share of global spending will increase from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the European share of spending will grow from USD 151.8 billion to USD 170-200 billion. Meanwhile, pharmerging countries will spend nearly 315-345 USD billion in 2021 from 242.9 in 2016.

Pharmacology, Pharmacovigilance, and Toxicology Societies and Associations Worldwide & Europe

European Association for Clinical Pharmacology and Therapeutics 

European Association for Veterinary Pharmacology and Toxicology 

European Behavioral Pharmacology Society 

European College of Neuropsychopharmacology 

European Society of Biochemical Pharmacology 

European Society of Developmental, Perinatal and Pediatric Pharmacology 

European Society of Ethnopharmacology 

Federation of European Pharmacological Societies 

Network Clinical Pharmacology in Germany

International Society of Pharmacovigilance

Drug Information Association

The International Society of Pharmacoepidemiology

The Drug Safety Research Unit

Regulatory Affairs Professionals Society

Society of Toxicology

International Union of Toxicology

Society of Environmental Toxicology and Chemistry

Federation of European Toxicologists and Societies of Toxicology

World Top Pharmacology Colleges

Harvard University

University of California

University of Oxford

University of Cambridge

University College London

Karolinska Institute

University of Michigan

The University of Nottingham

Leiden University

The University of Tokyo

Purdue University

Kings College London

Yale University

Johns Hopkins University

National University of Singapore

Leading Companies in the Generic Industry

Pfizer

Johnson & Johnson

Roche

Novartis

Merck & Co

Sanofi

GlaxoSmithKline (GSK)

Gilead

AbbVie

Bayer

Amgen

AstraZeneca

Sanofi

Bristol-Myers Squibb

Teva

Eli Lilly

Allergan

Novo Nordisk

Boehringer Ingelheim

Takeda

Celgene

Astellas Pharma

Shire

Mylan

Biogen

Daiichi Sankyo

Merck KGaA

Valeant

Otsuka

Sun

Eisai

Les

Past Conference Report

Pharmacology 2017

We would like to thank all our wonderful speakers, conference attendees, students, associations and guests for making Pharmacology 2017 a wonderful event!

Conference Series LLC hosted 9th World Congress on Pharmacology scheduled during September 04-06, 2017 at Hotel Novotel Marne la Vallée Noisy le Grand, Paris, France with the theme “Grooming the Pharmacological Boundaries for Drug Discovery and Development"

The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various scientists, researchers, students and leaders from the field of Pharmacology who made this event successful.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

  • Pharmacology
  • Neuropharmacology
  • Psychopharmacology
  • Advances in Pharmacological Research
  • Ethnopharmacology
  • Toxicology
  • Drug Screening and Discovery
  • Pharmacokinetics and Pharmacodynamics
  • Biochemical Pharmacology
  • Pharmacological Testing

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

  • Kjell Fuxe, Karolinska Institutet, Sweden
  • Zhi-Yi Zhang  TESARO, Inc., USA
  • María Esperanza Avella Vargas, Military University of New Granada, Columbia
  • Layla E Borham, Cairo University, Saudi Arabia
  • Sanaa S Botros, Theodor Bilharz Research Institute, Egypt

Conference series LLC thank all our expert presenters from all around the world which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

With the grand success of Pharmacology 2017, Conference Series LLC take the immense pleasure to announce the “14th World Congress on Pharmacology and Drug Safety" to be held during August 15-17, 2018 at Stockholm, Sweden.

For More details visit: https://pharmacology.annualcongress.com/


Past Reports  Gallery  

Pharmacology 2016

We would like to thank all our wonderful speakers, conference attendees, students, associations and guests for making Pharmacology 2016 a wonderful event!

Conference Series LLC hosted 3rd World Congress on Pharmacology scheduled during August 08-10, 2016 at Holiday Inn Birmingham City Centre, Birmingham, UK with the theme “(New) Drug Discovery: Multiple Trails towards a Broadway"

The conference had multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various scientists, researchers, students and leaders from the field of Pharmacology who made this event successful.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

  • Pharmacology
  • Neuropharmacology
  • Psychopharmacology
  • Advances in Pharmacological Research
  • Ethnopharmacology
  • Toxicology
  • Drug Screening and Discovery
  • Pharmacokinetics and Pharmacodynamics
  • Biochemical Pharmacology
  • Pharmacological Testing

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

  • CEJ van Rensburg (Connie Medlen), University of Pretoria, South Africa
  • Karen Mulkijanyan, Tbilisi State Medical University, Georgia
  • Alexander Kulikov, Siberian Division of Russian Academy of Sciences, Russia
  • Walber Toma, Santa Cecilia University, Brazil
  • P Brindha, SASTRA University, India
  • Myung Koo Lee, Chungbuk National University, Republic of Korea

Conference series LLC thank all our expert presenters from all around the world which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

With the grand success of Pharmacology 2016, Conference Series LLC take the immense pleasure to announce the “14th World Congress on Pharmacology and Drug Safety" to be held during August 15-17, 2018 at Stockholm, Sweden.

For More details visit: https://pharmacology.annualcongress.com/


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 17-18, 2019

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Clinical & Experimental Pharmacology Cardiovascular Pharmacology: Open Access Clinical Pharmacology & Biopharmaceutics World Journal of Pharmacology and Toxicology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos

 OR